UBS AM’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-24,360
| Closed | -$564K | – | 2732 |
|
|
2023
Q2 | $564K | Hold |
24,360
| – | – | ﹤0.01% | 2276 |
|
|
2023
Q1 | $564K | Sell |
24,360
-9,258
| -28% | -$214K | ﹤0.01% | 2276 |
|
|
2022
Q4 | $881K | Buy |
33,618
+5,076
| +18% | +$133K | ﹤0.01% | 1908 |
|
|
2022
Q3 | $561K | Buy |
28,542
+13,433
| +89% | +$264K | ﹤0.01% | 2294 |
|
|
2022
Q2 | $264K | Buy |
+15,109
| New | +$264K | ﹤0.01% | 2507 |
|
|
2019
Q4 | – | Sell |
-11,239
| Closed | -$59.6K | – | 2901 |
|
|
2019
Q3 | $59.6K | Buy |
11,239
+192
| +2% | +$1.02K | ﹤0.01% | 2705 |
|
|
2019
Q2 | $85.1K | Buy |
11,047
+5,707
| +107% | +$43.9K | ﹤0.01% | 2662 |
|
|
2019
Q1 | $106K | Hold |
5,340
| – | – | ﹤0.01% | 2561 |
|
|
2018
Q4 | $70.5K | Hold |
5,340
| – | – | ﹤0.01% | 2545 |
|
|
2018
Q3 | $196K | Hold |
5,340
| – | – | ﹤0.01% | 2453 |
|
|
2018
Q2 | $187K | Hold |
5,340
| – | – | ﹤0.01% | 2492 |
|
|
2018
Q1 | $248K | Buy |
+5,340
| New | +$248K | ﹤0.01% | 2287 |
|
|
2016
Q4 | – | Sell |
-2,660
| Closed | -$165K | – | 2708 |
|
|
2016
Q3 | $165K | Hold |
2,660
| – | – | ﹤0.01% | 2506 |
|
|
2016
Q2 | $150K | Hold |
2,660
| – | – | ﹤0.01% | 2526 |
|
|
2016
Q1 | $170K | Sell |
2,660
-36,666
| -93% | -$2.34M | ﹤0.01% | 2473 |
|
|
2015
Q4 | $5.53M | Buy |
+39,326
| New | +$5.53M | 0.01% | 1031 |
|
|
2015
Q3 | – | Sell |
-16,802
| Closed | -$2.55M | – | 2703 |
|
|
2015
Q2 | $2.55M | Buy |
+16,802
| New | +$2.55M | ﹤0.01% | 1295 |
|